SEC Filing Analysis: Elevance Health, Inc. (ELV)

Executive Summary

• Trading Significance: Low
• Key Takeaway: Routine annual executive compensation grants and associated tax withholding; no discretionary trading activity.
• Market Impact: Neutral - transaction size is negligible relative to market capitalization.

Company Information

Field	Value
Company	Elevance Health, Inc.
Ticker Symbol	ELV
CIK	0001156039
Industry	Healthcare Plans

Insider Information

Field	Value
Name	Wessling Erin M
CIK	0002084548
Title/Position	EVP & Chief Legal Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2026-03-03
Transaction Code	F (Payment of tax liability by withholding stock)
Security Type	Common Stock
Shares Disposed	417
Price Per Share	$284.03
Total Value	$118,440.51
Shares Owned After	7,579
Ownership Type	Direct

Note: Filing also includes grants of 2,976 RSUs and 11,754 Stock Options.

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$118,440
% of Market Cap	0.00017%
Shares Transacted	417
% of Shares Outstanding	0.00019%
Post-Transaction Ownership	7,579 shares (0.0034% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: With a market capitalization of $70.63 billion, this $118k transaction is mathematically insignificant.
• Ownership Concentration: The insider holds a minor stake relative to the 220.7 million shares outstanding.
• Dilution Impact: The combined grant of ~14,730 shares (RSUs + Options) represents approximately 0.006% of shares outstanding, resulting in negligible dilution.
• Transaction Significance: The disposition (Code F) is an automatic mechanism to pay taxes on vesting shares, not a signal of bearish sentiment.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This is a standard "sell-to-cover" transaction common during vesting periods. It does not reflect the insider's view on the stock's future performance.

Volume & Sentiment

• Expected Volume Impact: None. The volume is too small to affect liquidity.
• Sentiment Indicator: Neutral. The filing primarily documents the receipt of long-term incentives (options and RSUs).

Additional Context

Transaction Notes

• Equity Grants: The insider received significant long-term incentives: 2,976 RSUs vesting over 3 years and 11,754 stock options exercisable starting in 2027.
• Tax Withholding: The disposal of 417 shares was solely to satisfy tax withholding obligations related to the vesting of previously granted restricted stock (Footnote F2).